Researchers at the Korea Institute of Materials Science (KIMS) creaetd a Raman-spectroscopy-based urine test that can detect metabolic compounds that are produced by pancreatic and prostate cancers, potentially allowing for rapid and convenient cancer screening. The technology consists of a paper strip onto which a urine sample can be added. The…
Continue Reading
When the COVID-19 pandemic hit in early 2020 and everything shut down, it became imperative for healthcare provider organizations to adopt telemedicine to deliver care. But so many organizations had no telemedicine programs, and thus technology, in place.So, many provider organizations scrambled and turned to what they could. And in so…
Continue Reading
What You Should Know:– Primary care EHR Elation Health acquires cloud-based medical billing and payer connectivity provider Lightning MD, a platform that was created by nurses. Financial details of the acquisition were not disclosed.The acquisition is part of Elation Health’s bid to be a one-stop shop for all primary care — something that co-founder and CEO Kyna Fong, Ph.D., has been driving despite all the odds.As part of the acquisition, Elation will continue to support practices integrated with over 20 practice management and billing solutions connected via the Elation application programming interface (API).Lightning MDFounded in 2017 by registered nurses Kelly Schoenfeld and…
Continue Reading
Scientists at Brown University have designed an automated liquid chromatography tandem mass spectrometry (LC-MS/MS) system that allows clinicians to rapidly and easily process patient samples to determine levels of antidepressant drugs in the body. Getting the correct dose of antidepressant drugs into the bloodstream is important to ensure efficacy and avoid side-effects. However, current assays to measure the levels of such drugs in the blood are cumbersome, require large blood samples, and involve multiple time-consuming steps, limiting their use by clinicians. This new system requires very small sample volumes, and employs a robot liquid handling system that is commonly found […]…
Continue Reading
Healthcare analytics company MDI Health scored $20 million in Series A funding, bringing the company’s total funding to $26 million.Intel Capital led the round, with participation from Maverick Ventures Israel, alongside existing investors Fresh.Fund, Arc Impact, Hanaco Ventures, Jumpspeed Ventures, former Optum senior vice president Richard Montwill, Welltech Ventures and Basad Ventures.
Yoni Greifman, Intel Capital’s investment director, will join MDI’s board of directors.
WHAT IT DOES
Israel-based MDI offers an AI-enabled tool that provides medication risk analysis based on a patient’s medical records with the aim of preventing adverse drug reactions.
The funds will help the company scale its U.S. and Israeli research and…
Elation Health, which offers tools for telehealth, patient engagement and an EHR geared toward primary care providers, announced on Thursday that it had acquired billing and practice-management company Lightning MD.Elation said it would combine the billing and revenue cycle software with its tools to offer an all-in-one product in beta starting this summer. Practices who use other management and billing software through Elation’s API will still have that option.
Founded in 2017, Lightning MD partnered to integrate with Elation’s services last year.
“Healthcare technology is rapidly evolving, particularly in the primary care sector where we have the greatest opportunity to improve patient outcomes and…
As Reproductive Rights are Defunded and Debated Nationally, TBD Health Aims to Democratize Access to Inclusive Sexual Care
TBD Health, a sexual healthcare provider revolutionizing the medical landscape through unparalleled digital and in-person clinical care, today announced a $4.4 million seed round led by Tusk Venture Partners, with participation from Springdale Ventures, Human Ventures, Expansion VC, Starbloom Capital, Hyphen Capital, and The Community Fund along with several strategic angels. With this new financing, TBD Health is expanding to all 50 states, democratizing access to its sexual healthcare offerings, consisting of at-home STD testing and emergency contraception available via telehealth or in-person in its Las…
Grifols, a company that turns blood plasma into therapies for immunological disorders and other conditions, is laying off about 2,000 U.S. workers as part of a corporate restructuring projected to yield up to €400 million in annual cost savings, the biotech announced Wednesday.
The layoffs represent about 8% of the Barcelona-based company’s global workforce, but they will happen mainly in its U.S. plasma operations. That’s notable because as a company that relies on plasma, the U.S. is vital to its business. The starting point for Grifols’s therapies is blood plasma. Key to its drug-making process is fractionation, in which the protein components…
The U.S. Department of Health & Human Services (HHS) unveiled three new models Tuesday that will be tested by the CMS Innovation Center and aim to lower prescription drug costs. The models include access to $2 generic drugs.
The news is in response to President Joe Biden’s executive order issued in October, which directed HHS to find ways to lower prescription drug costs and improve access to drug therapies for those enrolled in Medicare and Medicaid health plans. The models are meant to build on the Inflation Reduction Act of 2022, which includes allowing Medicare to negotiate lower prescription drug prices for…
A slew of biotech companies are pursuing research that could overcome limitations of current cell therapies. Startup creator Replay has a new subsidiary pushing toward the front of the pack with a therapeutic candidate on track to start its first human test this summer—about one year after Replay emerged from stealth. It owes this rapid progress to a cell therapy pioneer’s technology that has already been de-risked by a big pharmaceutical company.
Replay calls itself a genome writing company. With operations split between San Diego and London, the private equity-backed business launched last July with $55 million and a suite of technologies…
